Bora CDMO Bora CDMO

X

List of Japan Drug Master File (JDMF) for 042LAQ1IIS Active Pharmaceutical Ingredient submitted to the Review Authority in Japan (PMDA) and listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Flag Finland
Digital Content Digital Content
220MF10025
Koivu-Mankkaan tie 6A, FI-02200 Esp...
2021-07-20
2008-01-23
Flag Germany
Digital Content Digital Content
URL Supplier Web Content
225MF10038
Echelon Institutional Area, Plot No...
2013-02-20
2013-02-20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
226MF10183
No. 7, Kunlunshan Road, Economic an...
2015-05-14
2014-09-30
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
226MF10143
Strada Rivoltana Km 6/7 20053 Rodan...
2014-07-31
2014-07-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
218MF10990
No. 1, Nan-Ke 8th Road, Shan-Hua, T...
2018-05-22
2006-12-18
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
303MF10140
No. 1, Nan-Ke 8th Road, Shan-Hua, T...
2021-09-02
2021-09-02
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
221MF10088
1479 Zhangheng Road, Zhangliang Hig...
2009-05-13
2009-05-13
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
230MF10129
No. 588, Middle Section, Peony Aven...
2020-08-18
2018-09-06
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
219MF10199
No. 588, Middle Section, Peony Aven...
2007-06-08
2007-06-08
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - 100MG/5ML (20MG/ML)
  • INJECTABLE;INJECTION - 300MG/15ML (20MG/ML)
  • INJECTABLE;INJECTION - 40MG/2ML (20MG/ML)
  • INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

Looking for 100286-90-6 / Irinotecan Hydrochloride API manufacturers, exporters & distributors?

Irinotecan Hydrochloride manufacturers, exporters & distributors 1

58

PharmaCompass offers a list of Irinotecan Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Irinotecan Hydrochloride manufacturer or Irinotecan Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Irinotecan Hydrochloride manufacturer or Irinotecan Hydrochloride supplier.

PharmaCompass also assists you with knowing the Irinotecan Hydrochloride API Price utilized in the formulation of products. Irinotecan Hydrochloride API Price is not always fixed or binding as the Irinotecan Hydrochloride Price is obtained through a variety of data sources. The Irinotecan Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Irinotecan Hydrochloride

Synonyms

100286-90-6, Irinotecan hcl, Topotecin, Campto, Camptothecin 11 hydrochloride, Camptosar

Cas Number

100286-90-6

Unique Ingredient Identifier (UNII)

06X131E4OE

About Irinotecan Hydrochloride

A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.

042LAQ1IIS Manufacturers

A 042LAQ1IIS manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 042LAQ1IIS, including repackagers and relabelers. The FDA regulates 042LAQ1IIS manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 042LAQ1IIS API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 042LAQ1IIS manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

042LAQ1IIS Suppliers

A 042LAQ1IIS supplier is an individual or a company that provides 042LAQ1IIS active pharmaceutical ingredient (API) or 042LAQ1IIS finished formulations upon request. The 042LAQ1IIS suppliers may include 042LAQ1IIS API manufacturers, exporters, distributors and traders.

click here to find a list of 042LAQ1IIS suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

042LAQ1IIS JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The 042LAQ1IIS Drug Master File in Japan (042LAQ1IIS JDMF) empowers 042LAQ1IIS API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the 042LAQ1IIS JDMF during the approval evaluation for pharmaceutical products. At the time of 042LAQ1IIS JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of 042LAQ1IIS suppliers with JDMF on PharmaCompass.

042LAQ1IIS Manufacturers | Traders | Suppliers

042LAQ1IIS Manufacturers, Traders, Suppliers 1
49

We have 7 companies offering 042LAQ1IIS

Get in contact with the supplier of your choice:

  1. Fermion Oy
  2. Fresenius Kabi AG
  3. Jiangsu Hengrui Medicine
  4. Olon S.p.A
  5. ScinoPharm Taiwan, Ltd
  6. Shanghai Desano Chemical Pharmaceutical Co., Ltd.
  7. Sinco Pharma
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY